Even as biomarker testing has become increasingly important for selecting the right lung cancer treatment, the time it takes to order these tests hasn't improved. Overall, the time from biopsy to biomarker results is about twice as long as most doctors think it is, and that wait can affect whether patients get started on the correct first-line treatment to match their cancer, such as targeted therapy or immunotherapy.